Validating saliva as a biological sample for cost-effective, rapid and routine screening for SARS-CoV-2

Autor: B.R. Ansil, Carolin Elizabeth George, Sindhulina Chandrasingh, Ashwin Viswanathan, Mukund Thattai, Padinjat Raghu, Santhosha Devadiga, Arun Geetha Harikumar, Pulleri Kandi Harsha, Indu Nair, Uma Ramakrishnan, Satyajit Mayor
Rok vydání: 2023
Předmět:
Zdroj: Indian Journal of Medical Microbiology. 45:100384
ISSN: 0255-0857
DOI: 10.1016/j.ijmmb.2023.100384
Popis: PurposeCompared to nasopharyngeal/oropharyngeal swabs, non-invasive saliva samples have enormous potential for scalability and routine population screening of SARS-CoV-2. In this study, we are investigating the efficacy of saliva samples relative to nasopharyngeal/oropharyngeal swabs for use as a direct source for the RT-PCR based SARS-CoV-2 detection.MethodsPaired nasopharyngeal/oropharyngeal swabs and saliva samples were collected from suspected positive SARS-CoV-2 patients and tested using RT-PCR. Generalised linear models were used to investigate factors that explain result agreement. Further, we used simulations to evaluate the effectiveness of saliva-based screening in restricting the spread of infection in a large campus such as an educational institution.ResultsWe observed 75.4% overall result agreement. Prospective positive samples stored for three or more days showed a drastic reduction in the probability of result agreement. We observed 83% result agreement and 74.5% test sensitivity in samples processed and tested within two days of collection. Our simulations suggest that a test with 75% sensitivity, but high daily capacity can be very effective in limiting the size of infection clusters in a workspace. Guided by these results, we successfully implemented a saliva-based screening in the Bangalore Life Sciences Cluster (BLiSC) campus.ConclusionThese results suggest that saliva may be a viable sample source for SARS-CoV-2 surveillance if samples are processed immediately. We strongly recommend the implementation of saliva-based screening strategies for large workplaces and in schools, as well as for population-level screening and routine surveillance as we learn to live with the SARS-CoV-2 virus.
Databáze: OpenAIRE